HSG, a national healthcare consulting firm, has expanded its performance improvement services to address healthcare worker shortages, burnout, and growing pains from physician practice acquisitions. These factors, coupled with billing delays and credentialing errors, can cause health care organizations severe losses and revenue cycle issues.
Asimily, a leading risk management platform for IoT devices and web-connected equipment, will accelerate its expansion within the healthcare industry with a strategic investment from MemorialCare Innovation Fund.
Citing Ballad Healths strong financial planning and considerable credit resiliency, Fitch Ratings today announced it has affirmed Ballad Healths A credit rating with a Stable outlook. This credit rating affects Ballad Healths series of debt instruments, as well as Ballad Healths planned refunding of variable rate demand bonds expected to be issued this summer.
UPshow, the leading on-premise performance marketing cloud powering over 30,000 screens, today launched UPshow SHIFT for Healthcare, a first-of-its-kind employee engagement platform designed specifically for the needs of top healthcare organizations.
Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and The American Society of Gene & Cell Therapy, today announced the launch of the Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report.
OptimumBank (OPHC) ended the year 2021 with total loans of $251,399,000 as compared with $154,919,000 from the year 2020 and $104,189,000 from the year ended 2019.
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: ChargePoint Holdings, Inc. (CHPT), PharmaDrug (LMLLF) DeepMarkit (MKTDF), and DraftKings Inc. (DKNG). Todays emerging technologies and lifestyle megatrends are unleashing trillion dollar market opportunities for disruptive innovation in how we live, work and play.
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Moderna, Inc. (MRNA), PharmaDrug Tilray, Inc. and Vinco Ventures (BBIG). Todays emerging technologies and lifestyle megatrends are unleashing trillion dollar market opportunities for disruptive innovation in how we live, work and play.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.